/PRNewswire/ Ascidian Therapeutics, a biotechnology company focused on treating human diseases by rewriting RNA, announced today three new appointments to.
Rocket Pharma RCKT CEO Gaurav Shah is on a mission to "change the narrative" when it comes to rare diseases. "We are enthusiastic about the potential of [our]…
Jonathan Schwartz, M.D., appointed Chief Gene Therapy Officer to enhance the Company’s focus on strategic application of gene therapy technologies to current and future therapeutic areasMark White, MB.ChB, named Chief Medical Officer; Dr. White brings proven track record in late-stage development and commercializati.
Jonathan Schwartz, M.D., appointed Chief Gene Therapy Officer to enhance the Company’s focus on strategic application of gene therapy technologies to current and future therapeutic areas
Mark. | April 4, 2023